Search Results 231-240 of 24399 for B cell lymphomas

  1. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell Lymphoma, Peripheral T-cell Lymphoma (any subtype). Subjects must have received at least one prior systemic chemotherapy and must have either ...

  2. Biological therapy for cancer - Mayo Clinic

    Related. Appendix cancer · Astrocytoma · Atypical teratoid rhabdoid tumor (ATRT) · Basal cell carcinoma · B-cell lymphoma · Brainstem tumor · Burkitt ...

  3. Dr. Yi Lin Archives - Mayo Clinic News Network

    CAR-T cell therapy aimed at killing B-cell blood ... multiple myeloma, leukemias and lymphomas. Manufacturing CAR-T cells ... lymphoma. Known as CAR-T cell therapy, ...

  4. Publications - David Li, M.D. - Mayo Clinic

    Intravascular Large B-cell Lymphoma Arising in a Spinal Hemangioma Hematopathology. 2023; 7(2). Iqbal M, Jiang L, Li KD, Moustafa MA, Kimbrough EO, Ansell SM, ...

  5. CAR-T cell therapy - Doctors & Departments - Mayo Clinic

    ... lymphoma, Follicular lymphoma, Hodgkin lymphoma, Cutaneous b-cell lymphoma ... B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn ...

  6. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

    The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large B- ...

  7. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Chronic lymphocytic leukemia, Acute myelogenous leukemia, B-cell lymphoma, Burkitt lymphoma, T-cell lymphoma, Follicular lymphoma. Show more areas of focus ...

  8. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell ...

  9. Hematology - Clinical trials

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  10. Clinical trials - Oncology (Medical)

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...